. 2018 Jan 19;38(3):951–976. doi: 10.1002/med.21484

Table 7.

Anti‐EV71 activity of 84 against EV71 C3 and C4a

	EV71 C3		EV71 C4a
Compound	EC₅₀ (μM)	CC₅₀ (μM)	EC₅₀ (μM)	CC₅₀ (μM)
Ribavirin	–	>39.96	–	>39.96
84	19.79 ± 10	>39.96	33.38 ± 0.61	>39.96

This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.